Neuroleptic-induced Klüver-Bucy syndrome.
D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001519:Behavior; D002746:Chlorpromazine / Q000009:adverse effects* / Q000627:therapeutic use; D005476:Fluphenazine / Q000009:adverse effects* / Q000627:therapeutic use; D006212:Hallucinations / Q000188:drug therapy; D006236:Handwriting; D006801:Humans; D008297:Male; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D010640:Phenothiazines / Q000009:adverse effects* / Q000627:therapeutic use; D011612:Psychosurgery / Q000009:adverse effects*; D012725:Sexual Behavior; D013577:Syndrome; D013702:Temporal Lobe / Q000502:physiology*
D000978:Antiparkinson Agents; D010640:Phenothiazines; D005476:Fluphenazine; D002746:Chlorpromazine